| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $19.4M | — | +1125.8% |
| R&D Expense | $95.5M | — | -4.3% |
| SG&A Expense | $104.9M | — | +82.8% |
| Operating Income | -$183.6M | — | -18.0% |
| Net Income | -$206.0M | — | -27.7% |
| EPS (Basic) | -$1.67 | — | -22.8% |
| EPS (Diluted) | -$1.67 | — | -22.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $129.8M | +6.0% | +76.2% |
| Accounts Receivable | $6.8M | -61.6% | +239.3% |
| Inventory | $154K | — | — |
| Current Assets | $839.5M | -8.5% | -12.2% |
| Total Assets | $1.27B | -10.6% | +0.7% |
| Current Liabilities | $199.2M | -1.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$145.5M | — | -10.5% |
| Capital Expenditures | $5.9M | — | +4.7% |
| Investing Cash Flow | $145.5M | — | +37.3% |
| Financing Cash Flow | $7.8M | — | +63.4% |
| Free Cash Flow | -$151.4M | — | -10.3% |
| +24.7% |
| Long-term Debt | $247.2M | +0.3% | -59.5% |
| Total Liabilities | $2.10B | +0.8% | +37.2% |
| Stockholders' Equity | -$826.6M | -25.3% | -210.3% |